Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
naltrexone (revia) (2 trials)
bortezomib (velcade) (1 trial)
copanlisib (aliqopa) (1 trial)
cytarabine (cytosar-u) (1 trial)
gemcitabine (gemzar) (1 trial)
Pegfilgrastim (1 trial)
rituximab (rituxan) (1 trial)
urea (1 trial)
Lymphoma (Phase 2)
Lymphoma, B-Cell (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 3)
Lymphoma, Mantle-Cell (Phase 2)
Lymphoma, Non-Hodgkin (Phase 2)
Lymphoma, T-Cell (Phase 2)
Trials (4 total)
Trial APIs (8 total)